Centivax
Developer of a broad-spectrum vaccine designed to treat and eradicate rapidly mutating pathogens. The company utilizes computational immune engineering to develop therapeutic monoclonal antibodies aga...
Valuation
$95M
Latest known
Share Price
N/A
Total Raised
$55M
Last Round
N/A